Lynsey Diersing
Family · Columbus, OHNPI 1043744535
Payments from drug & device makers
Across 317 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$729
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$541
- Axsome Therapeutics, Inc.$479
- Alkermes, Inc.$396
- Sunovion Pharmaceuticals Inc.$389
- plus $1K from 11 others
What the payments were for
- Food & beverage$4,89397%
- Education$1323%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 102 | $1,160 |
| Otsuka America Pharmaceutical, Inc. | 43 | $729 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 39 | $541 |
| Axsome Therapeutics, Inc. | 10 | $479 |
| Alkermes, Inc. | 19 | $396 |
| Sunovion Pharmaceuticals Inc. | 27 | $389 |
| Johnson & Johnson | 12 | $255 |
| Neurocrine Biosciences, Inc. | 12 | $237 |
| Teva Pharmaceuticals USA, Inc. | 15 | $226 |
| Avanir Pharmaceuticals, Inc. | 15 | $222 |
| Lundbeck LLC | 9 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $106 |
| Lucid Diagnostics Inc. | 4 | $72 |
| Indivior Inc. | 1 | $20 |
| Eisai Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Corium, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$494
- Auvelity$124
- ARISTADA INITIO$124
How this compares
$5,025 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 22 | $427 |
Paid to pharmacies, not to this prescriber.
Other family in Columbus
- Christina GastColumbus$66K
- Beth LoessinColumbus$34K
- Mary HurleyColumbus$15K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.